Patient-Funded Trials: Opportunity or Liability?

Cell Stem Cell 17 (2):135-137 (2015)
  Copy   BIBTEX

Abstract

Patient-funded trials are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols

Author Profiles

Alex John London
Carnegie Mellon University
Danielle M. Wenner
Carnegie Mellon University

Analytics

Added to PP
2015-10-16

Downloads
335 (#26,976)

6 months
23 (#47,050)

Historical graph of downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.
How can I increase my downloads?